ALFA FinderNSE filing, NSE: INFINIUM. Summary written from the filing by ALFA Finder's alert engine.
Infinium Pharmachem Ltd: key numbers
- Share price
- ₹275.05
- Market cap
- ₹382.8 Cr
- Revenue (annual)
- ₹189.6 Cr
- Net profit (annual)
- ₹12.15 Cr
- P/E (TTM)
- 31.5×Sector 48.6×
- Promoter holding
- 64.91%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Infinium Pharmachem Ltd
All →Infinium Pharmachem H1 FY27 Results: Net Profit ₹8.9 Cr, Up 58.9% YoY
Infinium Pharmachem Ltd reported revenue from operations of ₹129.7 Cr (+54.2% YoY) and net profit of ₹8.9 Cr (+58.9% YoY) for H1 FY27.
- Key figure
- Net profit ₹8.9 Cr · +58.9% YoY
Infinium Pharmachem Other Announcement
Infinium Pharmachem Limited filed its quarterly SEBI Regulation 74(5) compliance certificate for the period ending September 30, 2026, confirming all shares are held in demat form.
Infinium Pharmachem SME to Main Board Migration
Infinium Pharmachem Limited submitted its Annual Secretarial Compliance Report for 2026. This filing supports the company's application to migrate from the NSE SME Emerge platform to the Main Board.
Infinium Pharmachem Annual General Meeting
Infinium Pharmachem Limited announced that the resolution for migrating its equity shares from the NSE Emerge platform to the mainboard was passed via postal ballot.
Infinium Pharmachem Credit Rating
ICRA assigned a new [ICRA]BBB (Stable) rating to Infinium Pharmachem's ₹52.20 Crore credit facilities. The assignment covers cash credit, term loans, and unallocated limits from ICICI Bank and SBI.
Infinium Pharmachem Annual General Meeting
Infinium Pharmachem Limited held its 22nd Annual General Meeting on September 17, 2026. Shareholders transacted ordinary and special business, including director appointments and remuneration revisions.
Other board meeting date announcements
All →Anjani Foods Board Meeting Date
Anjani Foods has given prior intimation of a board meeting on 13 November 2026 to consider unaudited standalone and consolidated quarterly financial results for the period ended September 2026. The trading window is closed from 1 October 2026 until 48 hours after the board meeting.
Muzali Arts Board Meeting Date
Muzali Arts has given prior intimation of a board meeting on 14 November 2026 to consider unaudited Q2 and half-year results ended 30 September 2026. The trading window has been closed since 1 October 2026 until 48 hours after results are declared.
Arvaya Healthcare Board Meeting Date
Arvaya Healthcare Ltd intimated a board meeting on November 13, 2026 to approve unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. The trading window remains closed until 48 hours after results are declared.
Aspire & Innovative Advertising Board Meeting Date
Aspire & Innovative Advertising scheduled a November 14, 2026 board meeting to consider unaudited standalone results for the half year ended September 30, 2026. No results figures are attached yet.
SI Capital & Financial Services Board Meeting Date
S.I. Capital will hold a board meeting on 12 November 2026 to consider unaudited standalone quarterly results. This is a prior intimation for the meeting.
Axel Polymers Board Meeting Date
Axel Polymers will hold a board meeting on 13 November 2026 to consider unaudited half-year results. The trading window stays closed until 48 hours after results.